Search results for: '2026 china servic operations system industry market research report'

Microbiome research is on the rise following technological advancements and significant cost reductions in microbiome analysis. Research has unlocked the potential of microbiome in medical use cases, yielding tremendous insights on its nature, interactions, and impact within a host and in an external environment. Advanced studies on the role of mic...

In 2026, the global ADAS and autonomous driving market is transitioning to standardization, with Level 1 and Level 2 features becoming baseline across vehicle segments. This shift is driven by regulatory frameworks in North America and Europe, along with rising consumer demand for vehicle safety in emerging markets such as India and Southeast Asia....

More than 6,000 molecules are currently in clinical development across the pharmaceutical research and development (R&D) landscape, with more than 11,000 in the preclinical phase. The industry is witnessing the growth of small- to mid-segment pharma/biotech players making significant contributions to drug discovery and development pipelines. Across...

China's economy is poised for steady growth, projecting a 4.8% increase in GDP for 2024, following a 5.2% rise in 2023. This growth is supported by robust public investment, a resurgence in private consumption, and increased net exports. However, challenges such as an aging labor force, escalating debt levels, and geopolitical tensions around Taiwa...

China is entering a decade of macroeconomic transformation, with growth expected to moderate from an average of 5.7% between 2015 and 2025 to 3.7% between 2025 and 2035. This slowdown is being driven by structural factors like population aging, property sector correction, and shifting global trade dynamics. In this scenario, China is accelerating i...

21 Mar 2025  |  Global  |  Market Research

Pharmaceutical Clinical Contract Peripheral Services, Global, 2025–2030

The CRO Industry is Witnessing Transformational Growth Due to Industry Convergence and an Increasing Reliance on the Functional Service Provider (FSP) Model

Infographics

×

As trial volumes normalize after the COVID-19 pandemic, pharma and biopharma companies are re-focusing on their drug development pipelines. As a result, the market has been creating an increasing number of clinical trial outsourcing opportunities for CROs, with these service providers also refining their processes to ensure better clinical trial tu...

09 Feb 2022  |  Global  |  Frost Radar

Frost Radar™: Downstream Global Navigation Satellite System Services, 2021

A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines

Infographics

×

As the world moves toward automation and digitization, established and emerging industries will rely on geolocation. Accurate positioning, timing, and synchronization capabilities, for example, would reduce the cost of setting up new 5G network infrastructure and enable different location-based services and applications. High-accuracy downstream...

19 May 2017  |  Asia Pacific  |  Market Research

Strategic Analysis of Autonomous Cars in China, 2010–2025

Autonomous Cars Likely to be Commercialized among OEMs in China by 2030

Infographics

×

China is the largest passenger vehicle marketplace in term of sales and production volume in the world. Strong capitalization and the fast-growing automotive industry in China are likely to create high development opportunities in the global autonomous car market. The Chinese automotive industry is moving into autonomous car development. It is at t...

This Frost & Sullivan analysis examines the telematics sector in China, with a specific focus on commercial trucks. The data presented here refers to the total installed base of telematics, equivalent to the total number of commercial trucks that are subscribed to telematics. This includes historical data from 2021. The base year for this analysis ...